17.59 USD
▼-0.24-1.35%
盘后 17.94 0.00%
2026-11-19
市值
$2.96B
市盈率
8.18
EPS
2.09
股息率
—
52 周区间
15.86 – 30.96
成交量
1.45M
Beta
0.89
目标价
30.21
52W 低 15.8652W 高 30.96
价格走势
公司简介
Acadia Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a selective serotonin inverse agonist/antagonist for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 to treat the symptoms of Rett syndrome by reducing neuroinflammation and supporting sy...